CanadianSME Small Business Magazine’s Post

The #Wellness Market is estimated to be $4.5 Trillion #Investing in #Longevity  Join us for an insightful panel discussion on the exciting frontier of #longevity #investment. Explore how #venture capital and #private equity are driving #innovation in healthcare and longevity technologies, shaping the future of aging. Discover key trends, opportunities, and challenges in this rapidly evolving sector as we delve into the strategies and impact of investing in longevity for a healthier and more prosperous tomorrow.                                     Moderator:   Dr. Robert Fraser, CSO & President, Molecular You                                             Confirmed Speakers: ●      Cameron Burke, Partner-Technology & Innovation Banking, Fort Capital  ●      Terry Doyle, Managing Partner, TELUS Global Ventures ●      Brenda Irwin, Founder & Managing Partner, Relentless Venture Fund  ●      Brian Simmers, President, PHC Ventures Predictive Health Revolution join us for the 24th Annual Healthcare Summit, Longevity Health Living, Artificial Intelligence and Genomics.  “Exploring the Nexus of Longevity”, Health Living, AI, and Genomics 28/29/30 @HlthcareSumm https://lnkd.in/g7uRKfH Rob Fraser Molecular You Reboot Communications Ltd. Cameron Burke Terry Doyle Brenda Irwin Brian Simmers

LifeNome, a precision health company, is at the forefront of leveraging advanced genomics and technology to transform healthcare. Our CEO, Ali Mostashari, Ph.D, had an incredible experience at the Healthcare and Technology Investor Summit in Boston. The event provided a unique opportunity to discuss the challenges and potentials of integrating advanced technology into healthcare with a distinguished group of speakers. A key focus was on the need for specialized medical models trained on large-scale biological and medical datasets to enhance clinical diagnostics and treatment support. The insights shared by Martin Alexander Gershon, MD, JD, MPH, Peter Durlach, James Rogers, Randall Stanicky, Clark Hayes, Ray Liu, Sabine Wilhelm Ami Bhatt, MD, Petrina Kamya, Ph.D., Erik Lium, Michael Bouton, Felix Lee, were both amazing and insightful. Stay tuned for more updates from LifeNome, and join us on our journey to revolutionize precision medicine. Visit our website at www.lifenome.com to learn more and get involved. #LifeNome #HealthcareInnovation #MedicalAdvancements #PrecisionMedicine #HealthcareTransformation #JoinUs #Longevity #WomensHealth

LifeNome, a precision health company, is at the forefront of leveraging advanced genomics and technology to transform healthcare. Our CEO, Ali Mostashari, had an incredible experience at the Healthcare and Technology Investor Summit in Boston. The event offered a unique opportunity to discuss the challenges and potentials of integrating advanced technology into healthcare. The insights shared at the summit were both amazing and insightful. We are excited to apply these learnings to drive innovation in healthcare. LifeNome is actively seeking strategic partnerships in precision health, longevity, women’s health, and more. Stay tuned for more updates from LifeNome, and join us on our journey to revolutionize precision medicine. Visit our website at www.lifenome.com to learn more and get involved. #LifeNome #HealthcareInnovation #MedicalAdvancements #PrecisionMedicine 

✨Driving Health Innovation: Insights from Providence Health Care Ventures's Virtual Workshop Workshop Overview Earlier this month, Providence Health Care Ventures hosted a workshop titled "Unlocking Growth: How PHC Ventures Are Accelerating the Pace of Health Innovation to Implementation," for the ventures in CDL-Vancouver's Biomedical Engineering Stream. The session explored how PHC Ventures’ expertise in data, commercialization, and consulting can help ventures navigate their path to market success and enhance their product development strategies. 🎤 Meet the Speaker: Stuart Bowyer MSc Stuart Bowyer, Director of Business Development and Marketing at Providence Health Care Ventures, brought over 20 years of experience spanning digital health, precision medicine, and patient care to the workshop. Stuart shared practical strategies and invaluable insights to help ventures overcome challenges in health innovation. A big thank you to Stuart and PHC Ventures for their time and expertise in inspiring the next generation of transformative technologies!

Breaking into the healthcare market can be an uphill battle for #digitalhealth, #medtech, and #diagnostics startups. But that journey can be a bit more direct thanks to our Chief Medical Affairs Officer, Kevin M. Baumlin, MD, leverages over 30 years of clinical expertise to streamline this path for founders. In a conversation with Fierce Healthcare's Anastassia Gliadkovskaya, Kevin shares best practices for health system-startup partnerships – and shares his hot take on AI. https://lnkd.in/e7d_jekU

Across Europe, a rising number of healthtechs are looking to help tackle staff shortages across healthcare systems in the face of growing — and ageing — populations by automating tasks, both in clinical and admin settings. And VCs are taking note. Healthtech 1, a UK-based startup developing tech to automate admin in GP practices around the country, has raised a $3.5m seed round. The round was led by London-based VC Moonfire, and also featured accelerator Y Combinator — which Healthtech-1 participated in last year — alongside a number of angels. Healthtech-1’s first product, which automates new patient registrations, is currently deployed in 10% of GP practices in England, says co-founder Raj Kohli, who launched the company with ex-Monzo engineer ☝️ Peter Huang. By the end of 2025, it's targeting more than 90%. https://lnkd.in/eyGSUEwr

NVNG is excited to announce our investment in HealthX Ventures, an early stage VC looking for solutions in healthcare and life sciences and based in our home state of #Wisconsin. Healthcare is 19% of our US GDP and provides a huge opportunity here in the Midwest where many large payors, providers, employers, and builders are based. HealthX invests in enterprise digital health from pre-seed through series A, providing solutions for providers, payors, employers, and life sciences. #Madison, with Epic in our backyard, is the epicenter of health data. San Francisco, HealthX's other home base, is the epicenter of tech and innovation across sectors. These two locations create a unique opportunity for the firm. We’re excited to partner with Mark Bakken, Kristi Ebong, and the rest of the team, focusing on: - AI in Healthcare and Data Liquidity - Healthcare in the Home - Food as Medicine - Biopharma Value Chain - Consumer-Powered Care - Future of Healthcare Work We look forward to working with HealthX Ventures! #HealthcareInnovation #DigitalHealth #LifeSciences #VentureCapital #MidwestVC #AIMedicine #HealthTech #Biopharma #EnterpriseHealth #FutureOfHealthcare #WisconsinTech #Midwest #Innovation #Startups

📢We are thrilled lead the oversubscribed $15M Series A investment in Evidently, a pioneering AI platform transforming hospitals and large health systems by synthesizing fragmented medical data from disparate sources into actionable insights.   💪 We are deeply impressed by the exceptional founding team led by CEO Feng Niu and CPO Kalie Dove-Maguire, MD, whose track records and combined expertise in AI and healthcare make them uniquely equipped to tackle one of healthcare's most critical challenges.   🩺 Evidently’s platform has already delivered significant financial and efficiency gains at top US health systems, reducing administrative burdens while enhancing care quality. Feedback from early customers has been exceptionally positive, reinforcing the team’s mission to equip healthcare providers with advanced technology solutions.   ✅ This funding will enable Evidently to meet the rapidly growing demand for its ‘EvidentlyOne’ product while advancing new solutions for population health and clinical research. As part of the investment, Gülsah Wilke, supported by Sarah Kreik, will take a seat on Evidently’s board, bringing her experience as COO of healthtech scaleup Ada Health.   🎉We’re excited to back Feng Niu, Kalie Dove-Maguire, MD, and the entire Evidently team as they embark on the next phase of their growth. DN is joined by Framework Venture Partners and Fellows Fund along with existing investors Clear Ventures.   #VC #AI #HealthTech

DON Healthcare has announced a funding round of 2 million GBP. Are you a sophisticated investor who is genuinely interested in transforming lives and providing women with equal opportunities to thrive in business? DON Healthcare AI will be an innovative platform dedicated to bridging the gap between healthcare startups and the essential resources they need for growth and commercialization. By leveraging cutting-edge artificial intelligence, our platform matches startups with tailored service providers and sophisticated investors, creating an ecosystem that fosters innovation and accelerates success in the healthcare sector. Our platform offers a seamless user experience where healthcare startups can easily access a network of service providers—such as legal, regulatory, and marketing experts—while also connecting with investors seeking promising opportunities. By facilitating these connections, DON Healthcare AI enhances the chances of successful commercialization for startups, ultimately benefiting the healthcare industry as a whole. USP of DON Healthcare AI - AI market direction Female CEO 95% women run business Current Live company (in a manual process) British Company Feel free to contact us here - investors@donhealthcare.info More information on us - www.donhealthcare.info